TIA1 and tauopathy: RESULTS: Plasma TIA-1 levels were significantly reduced in AD, MCI-AD, VCI, and non-AD neurodegenerative diseases (synucleinopathies and tauopathies) compared to healthy controls, with the greatest reductions observed in non-AD neurodegenerative diseases.